BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND EP300, ENSG00000100393, 2033, RP1-85F18_1, p300 AND Prognosis
14 results:

  • 1. Lactate enhances NMNAT1 lactylation to sustain nuclear NAD
    Huang H; Wang S; Xia H; Zhao X; Chen K; Jin G; Zhou S; Lu Z; Chen T; Yu H; Zheng X; Huang H; Lan L
    Cancer Lett; 2024 Apr; 588():216806. PubMed ID: 38467179
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Tex10 interacts with STAT3 to regulate hepatocellular carcinoma growth and metastasis.
    Xiang X; Kuang W; Yu C; Li Y; Su Q; Tian Y; Li J
    Mol Carcinog; 2023 Dec; 62(12):1974-1989. PubMed ID: 37792308
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. EGR1 induces EMT in pancreatic cancer via a p300/SNAI2 pathway.
    Wang Y; Qin C; Zhao B; Li Z; Li T; Yang X; Zhao Y; Wang W
    J Transl Med; 2023 Mar; 21(1):201. PubMed ID: 36932397
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. METTL5 stabilizes c-Myc by facilitating USP5 translation to reprogram glucose metabolism and promote hepatocellular carcinoma progression.
    Xia P; Zhang H; Lu H; Xu K; Jiang X; Jiang Y; Gongye X; Chen Z; Liu J; Chen X; Ma W; Zhang Z; Yuan Y
    Cancer Commun (Lond); 2023 Mar; 43(3):338-364. PubMed ID: 36602428
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Skp2-mediated Zeb1 expression facilitates cancer migration by a ubiquitination-independent pathway.
    Wang HC; Luo CW; Chen TY; Chen YZ; Fang SY; Lai CY; Hung WC; Wu CC; Chen LT; Liu YC; Pan MR
    Life Sci; 2022 Dec; 311(Pt A):121135. PubMed ID: 36349605
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Exosome-derived FGD5-AS1 promotes tumor-associated macrophage M2 polarization-mediated pancreatic cancer cell proliferation and metastasis.
    He Z; Wang J; Zhu C; Xu J; Chen P; Jiang X; Chen Y; Jiang J; Sun C
    Cancer Lett; 2022 Nov; 548():215751. PubMed ID: 35718269
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. LncRNA-PACERR induces pro-tumour macrophages via interacting with miR-671-3p and m6A-reader IGF2BP2 in pancreatic ductal adenocarcinoma.
    Liu Y; Shi M; He X; Cao Y; Liu P; Li F; Zou S; Wen C; Zhan Q; Xu Z; Wang J; Sun B; Shen B
    J Hematol Oncol; 2022 May; 15(1):52. PubMed ID: 35526050
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The CTCF/LncRNA-PACERR complex recruits E1A binding protein p300 to induce pro-tumour macrophages in pancreatic ductal adenocarcinoma via directly regulating PTGS2 expression.
    Liu Y; Wang X; Zhu Y; Cao Y; Wang L; Li F; Zhang Y; Li Y; Zhang Z; Luo J; Deng X; Peng C; Wei G; Chen H; Shen B
    Clin Transl Med; 2022 Feb; 12(2):e654. PubMed ID: 35184402
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. C646 inhibits G2/M cell cycle-related proteins and potentiates anti-tumor effects in pancreatic cancer.
    Ono H; Kato T; Murase Y; Nakamura Y; Ishikawa Y; Watanabe S; Akahoshi K; Ogura T; Ogawa K; Ban D; Kudo A; Akiyama Y; Tanaka S; Ito H; Tanabe M
    Sci Rep; 2021 May; 11(1):10078. PubMed ID: 33980911
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Methylation-mediated LINC00261 suppresses pancreatic cancer progression by epigenetically inhibiting c-Myc transcription.
    Liu S; Zheng Y; Zhang Y; Zhang J; Xie F; Guo S; Gu J; Yang J; Zheng P; Lai J; Yin L; Wang H
    Theranostics; 2020; 10(23):10634-10651. PubMed ID: 32929371
    [No Abstract]    [Full Text] [Related]  

  • 11. Alignment of stroma fibers, microvessel density and immune cell populations determine overall survival in pancreatic cancer-An analysis of stromal morphology.
    Bolm L; Zghurskyi P; Lapshyn H; Petrova E; Zemskov S; Vashist YK; Deichmann S; Honselmann KC; Bronsert P; Keck T; Wellner UF
    PLoS One; 2020; 15(7):e0234568. PubMed ID: 32658932
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Insulin-like growth factor 1-induced enolase 2 deacetylation by HDAC3 promotes metastasis of pancreatic cancer.
    Zheng Y; Wu C; Yang J; Zhao Y; Jia H; Xue M; Xu D; Yang F; Fu D; Wang C; Hu B; Zhang Z; Li T; Yan S; Wang X; Nelson PJ; Bruns C; Qin L; Dong Q
    Signal Transduct Target Ther; 2020 May; 5(1):53. PubMed ID: 32398667
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Acetylation as a transcriptional control mechanism-HDACs and HATs in pancreatic ductal adenocarcinoma.
    Schneider G; Krämer OH; Schmid RM; Saur D
    J Gastrointest Cancer; 2011 Jun; 42(2):85-92. PubMed ID: 21271301
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Clinicopathological significance of cell cycle regulatory factors and differentiation-related factors in pancreatic neoplasms.
    Kamio Y; Maeda K; Moriya T; Takasu N; Takeshita A; Hirai I; Kimura W; Yamakawa M
    Pancreas; 2010 Apr; 39(3):345-52. PubMed ID: 20335778
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.